Explore daily insights on
Trulieve Cannabis surges 9.9% on historic NYSE listing approval
- Trulieve Cannabis shares surged 9.9% on June 5, closing at $11.74 on a massive 8.2x volume spike of 2.67 million shares.
- The company announced that its subordinate voting shares have been approved for listing on the New York Stock Exchange (NYSE).
- Trulieve will become the first U.S. cannabis company to list on the NYSE, marking a historic regulatory milestone for the industry.
Supporting datasets
Supporting queries
To surface this insight, Baselight ran 2 queries across its structured data. Each one is reproducible — open it, read the SQL, and rerun it yourself.
Conclusion
Price rose from $10.68 (June 4) to $11.74 (June 5), a 9.92% gain. Volume was 2,665,600 vs 20-day average of 326,268 (8.17x ratio).